Genetics of autoimmune diabetes mellitus
Jazyk angličtina Země Rakousko Médium print
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem, přehledy
- MeSH
- autoimunita imunologie MeSH
- autoprotilátky imunologie MeSH
- diabetes mellitus 1. typu genetika imunologie MeSH
- dítě MeSH
- dospělí MeSH
- genetická predispozice k nemoci MeSH
- haplotypy MeSH
- HLA-DQ alfa řetězec MeSH
- HLA-DQ antigeny genetika MeSH
- HLA-DQ beta řetězec MeSH
- HLA-DR antigeny genetika MeSH
- HLA-DR3 antigen genetika MeSH
- HLA-DR4 antigen genetika MeSH
- lidé MeSH
- polymorfismus genetický MeSH
- progrese nemoci MeSH
- rizikové faktory MeSH
- věkové faktory MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- srovnávací studie MeSH
- Názvy látek
- autoprotilátky MeSH
- HLA-DQ alfa řetězec MeSH
- HLA-DQ antigeny MeSH
- HLA-DQ beta řetězec MeSH
- HLA-DQA1 antigen MeSH Prohlížeč
- HLA-DQB1 antigen MeSH Prohlížeč
- HLA-DR antigeny MeSH
- HLA-DR3 antigen MeSH
- HLA-DR4 antigen MeSH
Autoimmune diabetes mellitus, called type 1 diabetes mellitus (T1DM), is caused by autoimmune destruction of islet beta cells in the pancreas. T1DM susceptibility loci mapped by different genome screening are IDDM1-IDDM18. It has been estimated that HLA (IDDM1) provides up to 40-50 % of the familial clustering of T1DM (LOD score of 65.8). Many studies have verified that DQB1*0302 is a strong susceptibility gene and that the heterozygous combination of DQA1*0301-DQB1*0302 on the HLA-DR4 haplotype and DQA1*0501-DQB1*0201 on the HLA-DR3 haplotype results in a synergistically increased risk of T1DM. The presence of predisposing genes in autoimmune diabetes decreases with age, probably due to increasing influence of environmental factors. Autoimmune diabetes with manifestation in adults may have partly different immunogenetic etiopathogenesis than autoimmune diabetes with manifestation in childhood. Compared to fast progressing adult-onset T1DM, slowly progressing adult-onset type 1 diabetes (LADA) might involve genes leading to a slow progressive beta-cells destruction.
Zobrazit více v PubMed
Hum Immunol. 2003 May;64(5):553-61 PubMed
Hum Mol Genet. 1996 Jul;5(7):1075-80 PubMed
Tissue Antigens. 1997 May;49(5):448-54 PubMed
Immunogenetics. 2000 Aug;51(10):765-70 PubMed
Nature. 1994 Sep 8;371(6493):130-6 PubMed
Tissue Antigens. 1994 Aug;44(2):110-9 PubMed
Diabetologia. 2000 Apr;43(4):507-14 PubMed
Diabetes. 1995 Jun;44(6):608-13 PubMed
Diabetes. 1992 Sep;41(9):1029-34 PubMed
J Clin Endocrinol Metab. 1997 Jan;82(1):143-6 PubMed
Immunol Today. 1993 Sep;14(9):426-30 PubMed
Hum Hered. 1974;24(3):273-84 PubMed
Nature. 2003 Oct 23;425(6960):805-11 PubMed
Tissue Antigens. 2000 Feb;55(2):162-5 PubMed
Diabetologia. 2001 Oct;44 Suppl 3:B51-9 PubMed
J Clin Endocrinol Metab. 2001 Aug;86(8):3754-60 PubMed
Science. 1998 Mar 13;279(5357):1737-40 PubMed
Am J Hum Genet. 1993 Jul;53(1):150-67 PubMed
Am J Hum Genet. 2001 Oct;69(4):820-30 PubMed
Nat Genet. 1995 Mar;9(3):284-92 PubMed
Genes Immun. 2002 Aug;3(5):235-49 PubMed
Immunogenetics. 1996;44(5):351-7 PubMed
Hum Mol Genet. 1996;5 Spec No:1443-8 PubMed
J Autoimmun. 1996 Jun;9(3):415-21 PubMed
Clin Exp Immunol. 1997 Oct;110(1):98-103 PubMed
Nature. 1986 Oct 2-8;323(6087):453-5 PubMed
Am J Hum Genet. 2001 Dec;69(6):1301-13 PubMed
Science. 1999 Jul 30;285(5428):727-9 PubMed
Diabetes. 2001 Jan;50(1):199-203 PubMed
Nat Genet. 1997 Mar;15(3):293-7 PubMed
Immunol Today. 1988;9(2):34-5 PubMed
Nat Genet. 1998 Jul;19(3):297-300 PubMed
Hum Mol Genet. 1997 Aug;6(8):1275-82 PubMed
Diabet Med. 1996 Mar;13(3):209-17 PubMed
Nature. 1982 Jan 7;295(5844):31-5 PubMed
Nat Genet. 1998 Jul;19(3):292-6 PubMed
Rev Immunogenet. 2000;2(1):88-94 PubMed
Science. 1995 May 26;268(5214):1185-8 PubMed
Proc Natl Acad Sci U S A. 1974 Mar;71(3):962-5 PubMed
Diabetes. 1984 Feb;33(2):176-83 PubMed
Diabetes. 1996 May;45(5):544-51 PubMed
Diabetes. 1998 Aug;47(8):1177-84 PubMed
